
Published on 15 April 2025
Turkey’s biotech manufacturing ambitions: Yerlika Biopharma’s strategic role
Author(s): GaBI Journal Editor
biopharma, biopharmaceutical, biosimilars, biotech, Turkey
263 views
Published on 15 April 2025
Author(s): GaBI Journal Editor
biopharma, biopharmaceutical, biosimilars, biotech, Turkey
263 views
Published on 14 April 2025
Author(s): Professor Alan Lyles, BSPharm, MPH, ScD, PhD (h.c.), Heinonen E, MD, PhD, Tolonen HM, MSc (Pharm), PhD, Linden K, MSc (Pharm), MSc (Econ), PhD, Sihvo S, PhD, Sarnola K, MSc (Pharm), MSc (Econ), PhD, Airaksinen M, MSc (Pharm), PhD
affordable medicines, automatic substitution, biological medicines, biosimilar, community pharmacy, Finland
187 views
Published on 25 March 2025
Author(s): Michael S Reilly, Esq, Ralph D McKibbin, MD, FACP, FACG, AGAF, Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP, Andrew Spiegel, Esq
interchangeable biosimilar, misinformation, switch studies
372 views
Published on 17 January 2025
Author(s): Robin Thorpe, PhD, FRCPath
DOI: 10.5639/gabij.2024.1303.032
380 views
Published on 14 January 2025
biopharmaceutical, critique, interchangeable biosimilar, meta-analysis, misinformation
520 views
Published on 18 December 2024
Author(s): Adjunct Professor Pekka Kurki, MD, PhD
interchangeable biosimilar, misinformation, switch studies
501 views
Published on 18 November 2024
Author(s): Vimal Sachdeva, MSc
authorization, best practice, harmonization, pharmaceuticals, recognition
DOI: 10.5639/gabij.2024.1303.034
1.544 views
Published on 07 November 2024
Author(s): GaBI Journal Editor
biosimilars, clinical development, commercialization, MENA (Middle East and North Africa)
DOI: 10.5639/gabij.2024.1303.037
819 views
Published on 06 May 2024
Author(s): Irene Krämer, PhD, Frank Erdnuess, PhD, Judith Thiesen, PhD
azacitidine, physicochemical stability, suspension for injection
DOI: 10.5639/gabij.2024.1302.023
1.005 views
Published on 11 September 2024
bortezomib, intravenous injection, physicochemical stability, subcutaneous injection
DOI: 10.5639/gabij.2024.1302.015
648 views
Published on 11 September 2024
cabazitaxel, concentrated solution, diluted infusion solution, HPLC, physicochemical stability
DOI: 10.5639/gabij.2024.1302.027
746 views
Published on 11 September 2024
carboplatin, concentrated solution, diluted infusion solution, HPLC, physicochemical stability
DOI: 10.5639/gabij.2024.1302.020
871 views